Does one-carbon metabolism and DNA methylation support regulatory T-cell function and prevent autoimmune dysregulation?

The relationship between cellular metabolism, epigenetic programming, and immune homeostasis is a central focus of modern immunology. This synthesis examines the role of one-carbon metabolism and DNA methylation in regulatory T-cell (Treg) function and how impaired methylation pathways contribute to autoimmune dysregulation.

Mechanistic pathways of immune regulation

One-carbon (1C) metabolism, which integrates the folate and methionine cycles, serves as the primary biochemical engine driving DNA methylation.

• Methyl Group Generation: One-carbon metabolic flux generates S-adenosylmethionine (SAM), the universal methyl donor utilized by DNA methyltransferases (DNMTs) to execute DNA methylation.
• Treg Identity and Stability: The lineage commitment and stability of Tregs depend on precise DNA methylation patterns. Specifically, demethylation of the Treg-specific demethylated region (TSDR/CNS2) within the Foxp3 enhancer is required for stable Foxp3 expression and suppressive function.
• Epigenetic Machinery: Conversely, active methylation of this locus by DNMT1, DNMT3a, or DNMT3b silences Foxp3 expression, leading to Treg phenotypic instability. The balance of these processes determines whether a cell maintains its suppressive capacity to preserve self-tolerance.

Clinical evidence in autoimmunity

Impaired DNA methylation is a well-established driver of autoimmune pathogenesis, altering immune cell profiles and contributing to conditions such as systemic lupus erythematosus, rheumatoid arthritis, and autoimmune thyroid diseases (AITD).

• Aberrant Cell Activation: Global or locus-specific DNA hypomethylation in CD4⁺ T-cells disrupts key regulatory checkpoints, leading to aberrant activation and skewed differentiation toward pro-inflammatory Th1 and Th17 phenotypes.
• Autoantibody Production: In AITD, these epigenetic shifts enhance B-cell activation, driving the production of hallmark autoantibodies such as thyroid peroxidase antibodies (TPO-Ab).
• Patient Profiles: Epigenetic mapping of patients with autoimmune thyroiditis reveals distinct whole-blood methylation profiles compared to healthy controls, highlighting methylation status as a crucial biological indicator of disease activity.

Nutritional cofactors and limitations

Because SAM is synthesized via the one-carbon cycle, its production relies on key dietary cofactors, notably folate and vitamin B12.

• Cofactor Deficiency: Deficiencies in B12 and folate restrict SAM availability and can impair systemic DNA methylation capacity. These deficiencies are frequently observed in patients with autoimmune thyroiditis, often exacerbated by co-existing autoimmune gastritis.
• Clinical Limitations: While correcting B12 or folate deficiencies successfully restores systemic methylation biochemistry and lowers hyperhomocysteinemia, clinical evidence demonstrating that supplementation directly reduces autoantibody titers or reverses thyroid-specific epigenetic dysregulation remains limited.

Bottom line

One-carbon metabolism provides the SAM methyl donors necessary for DNA methylation, which in turn regulates the stable Foxp3 expression required for Treg-mediated immune tolerance. Impaired DNA methylation and hypomethylation in T-cells are strongly associated with aberrant immune activation and autoantibody production in autoimmune conditions. While folate and B12 are essential for maintaining this biochemical machinery, their direct therapeutic role in reversing clinical autoimmune pathology requires further investigation.